Navigation Links
Scientists link genetic glitches to common childhood cancer
Date:8/17/2009

GAINESVILLE A multicenter team of childhood cancer researchers has discovered two genetic variations linked to an increased risk for acute lymphoblastic leukemia, or ALL, the most common childhood cancer in the United States.

Because these genetic glitches point to a specific subtype of the disease, identifying them in children who already have leukemia could improve treatment, says University of Florida researcher Meenakshi Devidas, Ph.D., a co-author on the study published online Sunday in Nature Genetics. Children with this specific subtype of ALL, known as B-hyperdiploid, tend to respond well to chemotherapy.

"The findings indicated inherited genetic variants contribute to the risk of a child getting ALL and likely contribute to a specific subtype of ALL," said Devidas, a research associate professor in the department of epidemiology and health policy research in the UF College of Medicine and co-director of the Children's Oncology Group Statistics and Data Center at UF. "So far, we have known that patients with this subtype respond well to chemotherapy, but we had no idea why that was."

Led by St. Jude Children's Research Hospital scientist Mary Relling, Pharm.D., the researchers conducted the first genomewide association study to check for genetic variations linked to the common cancer.

"This work indicates that as we approach full sequencing of cancer genomes, we should account for the fact that a gene can be made 'abnormal' via both inherited and acquired defects, and so we should not discount subtle inherited genomic variation as contributing to cancer risk," said Relling, chair of the St. Jude Children's Research Hospital department of pharmaceutical sciences and the paper's senior author. "With projects such as these, our collaboration with members of the Children's Oncology Group, which provided additional cases for genetic analysis, helped strengthen our findings."

To identify these genetic variations, the researchers analyzed the genetic makeup of about 400 children with acute lymphoblastic leukemia. After numerous tests, the researchers discovered two variations in tiny strands of DNA known as single-nucleotide polymorphisms that pointed to an increased risk for the disease and were also linked to the B-hyperdiploid subtype.

"If a patient has B-hyperdiploid ALL and has the genetic variation then we can at least project that this patient will do well," Devidas said. "Not that all patients do well, but if they have it the chances are higher."

Nearly one-quarter of children with cancer have ALL, National Cancer Institute statistics show. The disease occurs when abnormal white blood cells flood a person's bone marrow, killing the normal white blood cells needed to fight infections. Because of scientific research, the survival rate for this form of leukemia is around 85 percent, up from 5 percent in the 1960s, according to the National Cancer Institute.


'/>"/>

Contact: April Frawley Birdwell
afrawley@ufl.edu
352-273-5817
University of Florida
Source:Eurekalert

Related biology news :

1. Scientists take early steps toward mapping epigenetic variability
2. UOG scientists successfully compete for research grants
3. Canadian scientists identify gene that makes water striders glide across water
4. Scientists conduct shark survey off US East Coast
5. Scientists demonstrate importance of niche differences in biodiversity
6. Scientists devise efficient way of learning about complex corn traits
7. NIH stimulus funding supports Emory biomedical scientists
8. Scientists find universal rules for food-web stability
9. Scientists open doors to diagnosis of emphysema
10. Scientists decoding genomic sequences of H1N1 using isolates from outbreak in Argentina
11. Scientists uncork a potential secret of red wines health benefits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. ... company, announces the filing of its 2016 Annual Report on Form ... Exchange Commission. ... Form 10-K is available in the Investor Relations section of the ... on the SEC,s website at http://www.sec.gov . 2016 ...
(Date:4/11/2017)... , April 11, 2017 Crossmatch®, ... secure authentication solutions, today announced that it has ... Advanced Research Projects Activity (IARPA) to develop next-generation ... program. "Innovation has been a driving ... Thor program will allow us to innovate and ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):
(Date:7/25/2017)... ... July 25, 2017 , ... ... of Strategic Planning. His extensive background in consulting, development and marketing make ... marketing and differentiation consulting, business strategy development, new product marketing and global ...
(Date:7/24/2017)... ... July 24, 2017 , ... ... announced that the stock market news outlet had initiated coverage on Interpace ... that screens and identifies exposure, progression and risk analysis from specific cancers ...
(Date:7/20/2017)... ... July 20, 2017 , ... VIC Technology Venture Development™ (VIC™), ... of directors. This addition continues to strengthen and diversify VIC’s board. , "We ... Chairman. “He is a highly accomplished business executive with a broad range of experience ...
(Date:7/18/2017)... ... July 18, 2017 , ... Nanomedical Diagnostics, a ... announces the launch of a new NTA biosensor chip for use with its ... the kinetics of polyhistidine-tagged (His-tagged) molecules quickly and reliably. , “Recombinant proteins ...
Breaking Biology Technology: